Literature DB >> 20164783

Preprocedural score for risk of contrast-induced nephropathy in elective coronary angiography and intervention.

Mauro Maioli1, Anna Toso, Michela Gallopin, Mario Leoncini, Delio Tedeschi, Carlo Micheletti, Francesco Bellandi.   

Abstract

OBJECTIVES: To develop a simplified scoring system based on preprocedure clinical characteristics to predict contrast-induced nephropathy (CIN) before elective coronary angiography and percutaneous coronary intervention (PCI).
BACKGROUND: CIN is associated with increased mortality and morbidity following coronary angiography and PCI and accounts for increased hospital costs.
METHODS: Several baseline clinical characteristics of 1218 patients were considered as candidate univariate predictors of CIN (increase > or =0.5 mg/dl in serum creatinine within 5 days after contrast exposure). On the basis of the odds ratio at multivariate logistic regression, seven markers (with weighted scores) were identified as independent correlates of CIN: age at least 73 years (1), diabetes mellitus (2), left ventricular ejection fraction 45% or less (2), baseline serum creatinine value at least 1.5 mg/dl (2), baseline creatinine clearance 44 ml/min or less (2), posthydration creatinine > or = prehydration creatinine value (2) and one procedure effected within the past 72 h (3).
RESULTS: CIN occurred in 114 (9.4%) patients [range 1.1-52.1% for a low (< or =3) and very high (> or =9) risk score, respectively]; the odds of CIN increased significantly with each class (Cochran-Armitage chi-square, P < 0.0001) and the risk score allowed us to determine patients with low and high risk for postprocedure CIN (c-statistic = 0.86). These results were reproduced in a validation set.
CONCLUSION: Preprocedural clinical risk factors have different influences on the likelihood of CIN. Risk classification based on the most significant parameters can be used to predict CIN before contrast exposure. The simple scoring system proposed here provides a good estimate of the risk of CIN, allowing the interventional team to make adequate adjustment to the procedures.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20164783     DOI: 10.2459/JCM.0b013e328335227c

Source DB:  PubMed          Journal:  J Cardiovasc Med (Hagerstown)        ISSN: 1558-2027            Impact factor:   2.160


  27 in total

1.  Acute Kidney Injury Following In-Patient Lower Extremity Vascular Intervention: From the National Cardiovascular Data Registry.

Authors:  David M Safley; Adam C Salisbury; Thomas T Tsai; Eric A Secemsky; Kevin F Kennedy; R Kevin Rogers; Faisal Latif; Nicolas W Shammas; Lawrence Garcia; Matthew A Cavender; Kenneth Rosenfield; Anand Prasad; John A Spertus
Journal:  JACC Cardiovasc Interv       Date:  2021-02-08       Impact factor: 11.195

2.  Short-term rosuvastatin therapy prevents contrast-induced acute kidney injury in female patients with diabetes and chronic kidney disease: a subgroup analysis of the TRACK-D study.

Authors:  Jing Li; Yi Li; Biao Xu; Guoliang Jia; Tao Guo; Dongmei Wang; Kai Xu; Jie Deng; Yaling Han
Journal:  J Thorac Dis       Date:  2016-05       Impact factor: 2.895

3.  Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registry.

Authors:  Thomas T Tsai; Uptal D Patel; Tara I Chang; Kevin F Kennedy; Frederick A Masoudi; Michael E Matheny; Mikhail Kosiborod; Amit P Amin; John C Messenger; John S Rumsfeld; John A Spertus
Journal:  JACC Cardiovasc Interv       Date:  2014-01       Impact factor: 11.195

Review 4.  Contrast medium induced acute kidney injury: a narrative review.

Authors:  Valentina Pistolesi; Giuseppe Regolisti; Santo Morabito; Ilaria Gandolfini; Silvia Corrado; Giovanni Piotti; Enrico Fiaccadori
Journal:  J Nephrol       Date:  2018-05-25       Impact factor: 3.902

5.  Clinical prediction scores for type 1 cardiorenal syndrome derived and validated in chinese cohorts.

Authors:  Hong Cheng; Yi-Pu Chen
Journal:  Cardiorenal Med       Date:  2014-12-13       Impact factor: 2.041

6.  Diastolic dysfunction and contrast-induced nephropathy in patients undergoing coronary angiography.

Authors:  S Acikel; R Akdemir; H Kilic; G Cagirci; M Dogan; A B Yesilay; E Yeter
Journal:  Herz       Date:  2014-11-30       Impact factor: 1.443

7.  Derivation and validation of a risk score for contrast-induced nephropathy after cardiac catheterization in Chinese patients.

Authors:  Yu-mei Gao; Di Li; Hong Cheng; Yi-pu Chen
Journal:  Clin Exp Nephrol       Date:  2014-02-11       Impact factor: 2.801

8.  Risk factors for contrast induced nephropathy: a study among Italian patients.

Authors:  Salvatore Evola; Monica Lunetta; Francesca Macaione; Giuseppe Fonte; Gaspare Milana; Egle Corrado; Francesca Bonura; Giuseppina Novo; Enrico Hoffmann; Salvatore Novo
Journal:  Indian Heart J       Date:  2012-07-27

9.  Predicting contrast induced nephropathy in patients undergoing percutaneous coronary intervention.

Authors:  Rebecca Gosling; Javaid Iqbal
Journal:  J Thorac Dis       Date:  2019-07       Impact factor: 2.895

10.  Contrast induced acute kidney injury and the role of beta-blockers in its prevention.

Authors:  Umberto Barbero; Mario Iannaccone; Michele De Benedictis; Baldassarre Doronzo
Journal:  J Thorac Dis       Date:  2019-07       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.